Search For "sputnik v"
First component of Sputnik V shows 78.6-83.7 pc general efficacy against C
Updated : 4 years, 6 months ago IST
Moscow [Russia], September 13 (ANI): The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced the publication of a study in EClinicalMedicine (an open access peer-reviewed clinical journal published by The Lancet, one of the world's most respected medical journ
Read More
Argentina produced over 5 million doses of Russia's Sputnik V vaccine
Updated : 4 years, 7 months ago IST
Buenos Aires [Argentina], August 28 (ANI/Sputnik): The Argentine pharmaceutical company Richmond said it had produced more than 5 million doses of Russia's Sputnik V vaccine against COVID-19.
Read More
No proposal to change Covishield, Covaxin, and Sputnik V dose Interval: NT
Updated : 4 years, 7 months ago IST
New Delhi [India], August 26 (ANI): There is no proposal in consideration to change the dose interval between two COVID-19 vaccines--Covishield, Covaxin, and Sputnik V in India, National Technical Advisory Group on Immunisation's (NTAGI) chairman Dr Nk Arora said on Thursday.
Read More
Indonesia becomes 70th nation to authorise Sputnik V
Updated : 4 years, 7 months ago IST
Moscow [Russia], August 25 (ANI): Indonesia has approved the use of Russia's Sputnik COVID-19 vaccine for emergency use in the country.
Read More
Argentina's Laboratorios Richmond delivers first batch of Sputnik V vaccin
Updated : 4 years, 7 months ago IST
Moscow [Russia] August 12 (ANI): Argentina's Laboratorios Richmond has delivered the first batch of over 1 million doses of the Sputnik V vaccine produced in Argentina to the country's health ministry, the company said in a joint statement with the Russian Direct Investment Fund on Thursday.
Read More
Sputnik V jab 83 per cent effective against Delta variant, says Russian he
Updated : 4 years, 7 months ago IST
Moscow [Russia] August 11 (ANI): Russia's Sputnik V vaccine against COVID-19 is around 83 per cent effective against the Delta variant of coronavirus, Russian Direct Investment Fund (RDIF) said on Wednesday citing data collected by the health ministry.
Read More
TagBox to provide real-time cold chain monitoring solution to Dr. Reddy's
Updated : 4 years, 7 months ago IST
Bengaluru (Karnataka) [India], August 10 (ANI/PRNewswire): TagBox has announced that it is providing its BoxLens solution to Dr. Reddy's Laboratories for real-time temperature & location monitoring and traceability of the Sputnik V Covid-19 vaccine in India.
Read More
Mixing and matching of vaccines will help overcome shortage: Dr Gagandeep
Updated : 4 years, 7 months ago IST
New Delhi [India], August 5 (ANI): Mixing of COVID-19 vaccines should be done with the ones available in India, Dr Gagandeep Kang, Christian Medical College, Vellore's professor, and top microbiologist and virologist said on Thursday adding that it will help to overcome the vaccine shortage.
Read More
Delay in delivery of Sputnik V to be fully resolved in August
Updated : 4 years, 7 months ago IST
New Delhi [India], August 5 (ANI): The Sputnik V team on Wednesday confirmed that the temporary delay in delivery due to production scale-up will be fully resolved in August.
Read More
Combinations of Sputnik V component with three other vaccines demonstrates
Updated : 4 years, 7 months ago IST
Moscow [Russia] August 5 (ANI): The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results.
Read More
Trial results of Sputnik V, AstraZeneca booster dose expected this week
Updated : 4 years, 7 months ago IST
New Delhi [India], August 4 (ANI): After Dr Reddy's Laboratories issued a statement on Monday regarding the availability of 'Made in India' Sputnik V COVID-19 doses from September /October, the Sputnik V team confirmed it was scaling up its vaccine production capacity.
Read More
Discussions yet not over between govt, US-based manufacturers for procurin
Updated : 4 years, 7 months ago IST
New Delhi [India], August 3 (ANI): Discussions and negotiations are still not over between the government and US-based COVID-19 vaccine manufacturers for procuring their vaccine, said Dr NK Arora, Chief of National Immunization Technical Advisory Group (NTAGI) on Monday.
Read More